![]() ![]() If you are taking other medicines on a regular basis, including complementary or traditional medicines, the use of GAVISCON LIQUID ANISEED with these medicines may cause undesirable interactions.Ī time-interval of 2 hours should be considered between GAVISCON LIQUID ANISEED intake and the administration of other medicinal products, especially tetracyclines, flouroquinolones, iron salts, thyroid hormones, chloroquine, bisphosphates, and estramustine. Large doses of GAVISCON LIQUID ANISEED may affect the absorption of other oral medicines. Taking other medicines with GAVISCON LIQUID ANISEED: High blood levels of calcium can occur following the regular use of calcium carbonate. Important information about some of the ingredients of GAVISCON LIQUID ANISEED: GAVISCON LIQUID ANISEED has no or negligible influence on driving or the ability to operate tools or machines. Clinical data do not suggest that GAVISCON LIQUID ANISEED has an effect on human fertility. ![]() GAVISCON LIQUID ANISEED has no negative effect in parental or offspring fertility or reproduction. If you are pregnant or breast-feeding your baby while taking this medicine, please consult your doctor, pharmacist or other healthcare professional of advice. Gaviscon can be used during breastfeeding. No effects of GAVISCON LIQUID ANISEED have been shown in breast fed newborns/infants of treated mothers. GAVISCON LIQUID ANISEED is used for heartburn of pregnancy. This medicine is usually taken after meals and at bedtime. Taking GAVISCON LIQUID ANISEED with food and drink: Care needs to be taken in treating patients with hypercalcaemia, nephrocalcinosis, and recurrent calcium containing renal calculi. ![]() low calcium levels) or cirrhosis of the liver. If you have kidney disease, electrolyte imbalances (e.g.Take special care with GAVISCON LIQUID ANISEED: Contains methyl parahydroxybenzoate and propyl parahydroxybenzoate: May cause allergic reactions If you are hypersensitive (allergic) to sodium alginate or any other ingredients.Randomised clinical trial: the effectiveness of Gaviscon Advance vs non‐alginate antacid in suppression of acid pocket and post‐prandial reflux in obese individuals after late‐night supper. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease. Thomas E, Wade A, Crawford G, Jenner B, Levinson N, Wilkinson J. ![]() In: Drug Therapy for Gastrointestinal and Liver Diseases. Drug therapy of gastro-oesophageal reflux. Galmiche JP, Bourreille A, Scarpignato C. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor. Randomised clinical trial: alginate (Gaviscon Advance) vs. Reimer C, Lødrup AB, Smith G, Wilkinson J, Bytzer P. Alginate-Antacid (Gaviscon Double Action) Chewable Tablets Reduce Esophageal Acid Exposure in Chinese Patients with Gastroesophageal Reflux Disease and Heartburn Symptoms. Yuan YZ, Fang JY, Zou DW, Levinson N, Jenner B, Wilkinson J. GAVISCON- aluminum hydroxide and magnesium carbonate liquid label. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |